×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VIVO – meridian bioscience inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VIVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
09:10 am
vivo
VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million
Low
Report
VivoPower Receives Nasdaq Approval of Ticker “TEMB” for Planned Tembo Listing at a Targeted Valuation of $838 Million
3/20
09:32 am
vivo
VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float
Medium
Report
VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float
3/18
09:00 am
vivo
VivoPower Terminates $180 Million F-3 Registration Statement
High
Report
VivoPower Terminates $180 Million F-3 Registration Statement
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/27
Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak
20.8%
3/17 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 16.8%
3/13 Form 4 MERIDIAN BIOSCIENCE INC For: Mar 12 Filed by: Kenny John P. 15.1%
4/2 MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH 10.6%
4/14 Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests 8.5%
7/30 Q3/2019 6/30/2019 EPS 0.160 ZacksConsensus 0.100 ActVsEst 0.060 - Beat 7.2%
3/16 FDA clears Meridian Bioscience's new Curian analyzer and Curian HpSA assay [Seeking Alpha] 6.0%
4/16 Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020 5.4%
10/15 Form 4 MERIDIAN BIOSCIENCE INC For: Oct 11 Filed by: Kenny John P. 5.0%
2/7 Meridian Bioscience Inc (VIVO) Q1 2020 Earnings Call Transcript [The Motley Fool] 4.9%
3/17 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 16.8%
3/13 Form 4 MERIDIAN BIOSCIENCE INC For: Mar 12 Filed by: Kenny John P. 15.1%
4/2 MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH 10.6%
4/14 Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests 8.5%
7/30 Q3/2019 6/30/2019 EPS 0.160 ZacksConsensus 0.100 ActVsEst 0.060 - Beat 7.2%
3/16 FDA clears Meridian Bioscience's new Curian analyzer and Curian HpSA assay [Seeking Alpha] 6.0%
4/16 Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020 5.4%
10/15 Form 4 MERIDIAN BIOSCIENCE INC For: Oct 11 Filed by: Kenny John P. 5.0%
2/7 Meridian Bioscience Inc (VIVO) Q1 2020 Earnings Call Transcript [The Motley Fool] 4.9%
TOP News Decliners
11/7
Q4/2019 9/30/2019 EPS 0.130 ZacksConsensus 0.090 ActVsEst 0.040 - Beat
-16.2%
2/7 Q1/2020 12/31/2019 EPS 0.100 ZacksConsensus 0.060 ActVsEst 0.040 - Beat -15.7%
1/27 Meridian Bioscience joins coronavirus rally, up 28% [Seeking Alpha] -10.9%
1/27 Form 8-K MERIDIAN BIOSCIENCE INC For: Jan 27 -10.8%
2/6 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.2%
8/14 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.1%
9/25 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.5%
11/8 Meridian Bioscience Inc (VIVO) Q4 2019 Earnings Call Transcript [The Motley Fool] -4.4%
2/26 Form 4 MERIDIAN BIOSCIENCE INC For: Feb 25 Filed by: McIlwraith John -4.2%
3/10 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%
2/7 Q1/2020 12/31/2019 EPS 0.100 ZacksConsensus 0.060 ActVsEst 0.040 - Beat -15.7%
1/27 Meridian Bioscience joins coronavirus rally, up 28% [Seeking Alpha] -10.9%
1/27 Form 8-K MERIDIAN BIOSCIENCE INC For: Jan 27 -10.8%
2/6 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.2%
8/14 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.1%
9/25 Meridian Bioscience, Inc. (NASDAQ: VIVO) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.5%
11/8 Meridian Bioscience Inc (VIVO) Q4 2019 Earnings Call Transcript [The Motley Fool] -4.4%
2/26 Form 4 MERIDIAN BIOSCIENCE INC For: Feb 25 Filed by: McIlwraith John -4.2%
3/10 Meridian Bioscience, Inc. (NASDAQ: VIVO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: